Acrodisc WBC (white blood cell) syringe filter

The Acrodisc™ White Blood Cells (WBC) syringe filter contains Leukosorb media

Acrodisc™ WBC syringe filter, a Pall Life Sciences product, uses proprietary filter technology to separate leukocytes from whole blood in less than 10 min for 10 mL.

The Acrodisc White Blood Cells (WBC) syringe filter contains Leukosorb media. Leukosorb is a fibrous matrix that uses a multimodal approach of size exclusion and adsorption to capture and recover leukocytes from whole blood samples while allowing Red Blood Cells (RBCs) and platelets to flow through the membrane.

Materials of Construction

Filter Media: Leukosorb Housing: Polypropylene

Effective Filtration Area

3.9 cm2

Sample Volume Range

1 – 12 mL

Inlet/Outlet Connections

Sterile: Female luer-lock (clear) inlet/ female luer-lock (white) outlet.

Typical Hold up Volume

Hold up volume < 2 mL, with total sample volume = 12 mL

Maximum Operating Pressure

v30 psi

Maximum operating Temperature

34°C

Shelf Life

3 years

Sterility

Sterile

Applications

Our premium Acrodisc WBC Syringe Filter is designed specifically to capture and recover Leukocytes while separating red blood cells and platelets, thereby providing scientists with a simple and efficient method to isolate cells needed for use in a variety of research applications including:

Leukocyte depletion
Whole WBC capture
Ficol separations
Lymphocyte recovery for cell therapy
Stem cell research
With the Acrodisc WBC filter, the uniquely designed filter does all the difficult capture work, resulting in more efficient white blood cell separation as compared to Buffy Coat density gradient methods. The Acrodisc White Blood Cell Syringe Filter yields greater cell capture and recovery with less sample compared to larger filter formats and also exudes very low hold up volume as compared to larger white blood cell isolation filters (hold up volume < 2 mL, with total sample volume = 12 mL.

以LNP为载体的In vivo CAR-T应用进展

主讲嘉宾:向涛

课程分类:线上产品课程 – 细胞与基因治疗

  1. 以LNP为递送载体的In vivo CAR-T技术的全球管线情况介绍
  2. 以LNP为递送载体的In vivo CAR-T的最新研究与技术进展
  3. Cytiva在以LNP为载体的In vivo CAR-T应用方向上的整体解决方案

相关文档下载

相关产品推荐

搜索未找到相关记录,请换个查询条件尝试。